Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PHEZ | ISIN: SE0012558617 | Ticker-Symbol: L7R
Stuttgart
05.06.25 | 08:10
0,000 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
LIPIDOR AB Chart 1 Jahr
5-Tage-Chart
LIPIDOR AB 5-Tage-Chart

Aktuelle News zur LIPIDOR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoXFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.06.2025352The following instruments on Boerse Frankfurt do have their last trading day on 02.06.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.06.2025ISIN NameCA19243C1005 COGNETIVITY...
► Artikel lesen
LIPIDOR Aktie jetzt für 0€ handeln
26.05.Delisting of Lipidor AB from Nasdaq First North Growth Market160On May 26, 2025, Lipidor AB was declared bankrupt by the Stockholm District Court. According to item 8.2.7 of the Nasdaq First North Growth Market Rulebook, the exchange may decide to delist...
► Artikel lesen
26.05.XFRA L7R: AUSSETZUNG/SUSPENSION93DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILLIPIDOR AB L7R SE0012558617...
► Artikel lesen
26.05.Suspension of Trading in Lipidor AB at FNSE1462025-05-26T06:33:44Z Suspension At Trading Venue FNSE Due to Non Disclosure Of Inside Information About The Issuer Or Financial Instrument Ongoing: True Comments: Nasdaq Stockholm has, to the extent...
► Artikel lesen
25.05.Lipidor AB: Lipidor applies for bankruptcy144STOCKHOLM, Sweden, 25th May 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that the Company's board has resolved to file for bankruptcy on behalf of the Company. The...
► Artikel lesen
24.05.Lipidor AB: Lipidor announces today negative results from the company's Phase III clinical study of AKP02G2 for psoriasis87STOCKHOLM, Sweden, 24th May 2025 - (Nasdaq First North: LIPI) reports negative results from a Phase III clinical study of the AKP02G2 cutaneous spray for mild to moderate plaque psoriasis. The study...
► Artikel lesen
19.05.Lipidor AB: Lipidor announces database lock in its Phase III clinical study of the psoriasis candidate AKP02G2108STOCKHOLM, Sweden, 19th May 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that the company's Phase III study of AKP02G2 for the treatment of psoriasis has reached...
► Artikel lesen
17.03.Lipidor AB: Lipidor announces all patients enrolled in ongoing Phase III study132STOCKHOLM, Sweden, 17th March 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that all patients in the ongoing Phase III study for the drug candidate AKP02G2 have been...
► Artikel lesen
28.02.Lipidor AB: Lipidor AB (publ) publishes year-end report for 2024190STOCKHOLM, Sweden, 28th February 2025 - Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its year-end report for the period January - December 2024. The report is available...
► Artikel lesen
21.01.Lipidor AB: Lipidor announces half of patients enrolled in ongoing Phase III study481STOCKHOLM, Sweden, 21st January 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that half of the patients in the ongoing Phase III study for the drug candidate AKP02G2...
► Artikel lesen
20.11.24Lipidor AB: Lipidor publishes CEO statement for the quarter: "Study results expected by the end of Q1 2025"129STOCKHOLM, Sweden, 20 November 2024 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today provides an update on the business from CEO Ola Holmlund, also announcing a company presentation...
► Artikel lesen
28.08.24Lipidor AB: Lipidor AB (publ) publishes interim report for Q2 2024131STOCKHOLM, Sweden, 28 August 2024 - Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the period January - June 2024. The report is available on the...
► Artikel lesen
27.06.24Nasdaq Stockholm AB: New equity right for trading, Lipidor AB TO21.151At the request of Lipidor AB, Lipidor AB equity rights will be traded on First North Growth Market as from June 28, 2024. Security name: Lipidor AB TO2 ------------------------------ Short...
► Artikel lesen
26.06.24Nasdaq Stockholm AB: The observation status for Lipidor AB is removed318On December 19, 2022, the shares in Lipidor AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position. On April...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1